BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 14604081)

  • 1. Onchocerciasis (river blindness).
    Borup LH; Peters JS; Sartori CR
    Cutis; 2003 Oct; 72(4):297-302; quiz 296. PubMed ID: 14604081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Onchocerciasis].
    Enk CD; Gardlo K; Ruzicka T; BenEzra D
    Hautarzt; 2003 Jun; 54(6):513-7. PubMed ID: 12759735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemotherapy of onchocerciasis XX: ivermectin in combination with albendazole.
    Awadzi K; Addy ET; Opoku NO; Plenge-Bönig A; Büttner DW
    Trop Med Parasitol; 1995 Dec; 46(4):213-20. PubMed ID: 8826100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Onchocerciasis presenting with lower extremity, hypopigmented macules.
    Vernick W; Turner SE; Burov E; Telang GH
    Cutis; 2000 May; 65(5):293-7. PubMed ID: 10826090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of semiannual treatments of ivermectin on the prevalence and intensity of Onchocerca volvulus skin infection, ocular lesions, and infectivity of Simulium ochraceum populations in southern Mexico.
    Rodriguez-Perez MA; Rodriguez MH; Margeli-Perez HM; Rivas-Alcala AR
    Am J Trop Med Hyg; 1995 May; 52(5):429-34. PubMed ID: 7771609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An itching disease from the tropics: onchocerciasis as an imported disease].
    de Vries PJ; Kingma WP; Wetsteyn JC
    Ned Tijdschr Geneeskd; 1994 Sep; 138(36):1793-8. PubMed ID: 7935904
    [No Abstract]   [Full Text] [Related]  

  • 7. Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history.
    Ali MM; Baraka OZ; AbdelRahman SI; Sulaiman SM; Williams JF; Homeida MM; Mackenzie CD
    J Infect Dis; 2003 Feb; 187(4):714-7. PubMed ID: 12599094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivermectin treatment of ocular onchocerciasis.
    Taylor HR
    Acta Leiden; 1990; 59(1-2):201-6. PubMed ID: 2198751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular approaches to the control of onchocerciasis in Mexico].
    Rodríguez-Pérez MA
    Rev Latinoam Microbiol; 2005; 47(3-4):112-29. PubMed ID: 17061536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Head nodding syndrome and river blindness: a parasitologic perspective.
    Kaiser C; Pion S; Boussinesq M
    Epilepsia; 2009 Oct; 50(10):2325-6. PubMed ID: 19785668
    [No Abstract]   [Full Text] [Related]  

  • 11. [Onchocerciasis in travelers to the tropics].
    Junghanss T; Weiss N
    Dtsch Med Wochenschr; 1990 Sep; 115(37):1392-6. PubMed ID: 2401191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onchocerciasis--river blindness.
    Enk CD
    Clin Dermatol; 2006; 24(3):176-80. PubMed ID: 16714198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana.
    Awadzi K; Attah SK; Addy ET; Opoku NO; Quartey BT; Lazdins-Helds JK; Ahmed K; Boatin BA; Boakye DA; Edwards G
    Ann Trop Med Parasitol; 2004 Jun; 98(4):359-70. PubMed ID: 15228717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Onchocerciasis.
    Taylor HR
    Int Ophthalmol; 1990 May; 14(3):189-94. PubMed ID: 2188920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of onchocerciasis--the next generation.
    Hotez PJ
    Lancet; 2007 Jun; 369(9578):1979-1980. PubMed ID: 17574078
    [No Abstract]   [Full Text] [Related]  

  • 16. The burden of skin disease and eye disease due to onchocerciasis in countries formerly under the African Programme for Onchocerciasis Control mandate for 1990, 2020, and 2030.
    Vinkeles Melchers NVS; Stolk WA; van Loon W; Pedrique B; Bakker R; Murdoch ME; de Vlas SJ; Coffeng LE
    PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009604. PubMed ID: 34310602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. River blindness eliminated in Colombia.
    West S; Munoz B; Sommer A
    Ophthalmic Epidemiol; 2013 Oct; 20(5):258-9. PubMed ID: 23968291
    [No Abstract]   [Full Text] [Related]  

  • 18. Ivermectin in human onchocerciasis: a clinical-pathological study of skin lesions before and three days after treatment.
    Vuong PN; Traoré S; Wanji S; Diarrassouba S; Balaton A; Bain O
    Ann Parasitol Hum Comp; 1992; 67(6):194-6. PubMed ID: 1301733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of ivermectin treatment alone and when in parallel with Simulium neavei elimination on onchocerciasis in Uganda.
    Ndyomugyenyi R; Tukesiga E; Büttner DW; Garms R
    Trop Med Int Health; 2004 Aug; 9(8):882-6. PubMed ID: 15303993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 5 years of annual treatment with ivermectin (Mectizan) on the prevalence and morbidity of onchocerciasis in the village of Gami in the Central African Republic.
    Kennedy MH; Bertocchi I; Hopkins AD; Meredith SE
    Ann Trop Med Parasitol; 2002 Apr; 96(3):297-307. PubMed ID: 12061976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.